Skip to content

A trial to test the safety of herbal wound dressing

Phase 1 studies for assessment of safety of wound dressing (SKBPARA) comprising botanicals.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012166
Enrollment
100
Registered
2018-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: SKBPARA: Apply wound dressing on healthy skin for 4 days. Control Intervention1: No comparator agent: Not applicable

Sponsors

SK Biolabs
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy Human Volunteers

Exclusion criteria

Exclusion criteria: Patients suffering from any disease

Design outcomes

Primary

MeasureTime frame
Any toxic side effects after application of SKBPARA on skin such as redness, itching, burning, irritation, urticaria, fever, nausea etc.Timepoint: 4 Hours

Secondary

MeasureTime frame
Any toxic side effects after application of SKBPARA on skin such as redness, itching, burning, irritation, urticaria, fever, nausea etc.Timepoint: 4 Days

Countries

India

Contacts

Public ContactAshok Kumar

SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs)

ashok846@gmail.com8126688922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026